Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9896478 Antibody purification by cation exchange chromatography

Patent 9896478 was granted and assigned to Genentech on February, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Date Filed
November 3, 2014
0
Date of Patent
February 20, 2018
0
Patent Applicant
Genentech
Genentech
0
Patent Application Number
14531880
0
Patent Citations Received
‌
US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer
0
‌
US Patent 11654105 Subcutaneous HER2 antibody formulations
0
‌
US Patent 11655305 Treatment of metastatic breast cancer
0
‌
US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer
0
‌
US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
0
Patent Inventor Names
Benedicte Andree Lebreton
0
Deborah Ann O'Connor
0
Aurelia Safta
0
Mandakini Sharma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9896478
0
Patent Primary Examiner
‌
Daniel E Kolker
0

Find more entities like US Patent 9896478 Antibody purification by cation exchange chromatography

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.